Soc. Generale Knock-Out AZN/ DE000SD8WD02 /
| 04/11/2024 21:49:06 | Chg.+0.010 | Bid21:59:06 | Ask21:59:06 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 3.940EUR | +0.25% | 3.930 Bid Size: 800 |
4.010 Ask Size: 800 |
Astrazeneca PLC ORD ... | 76.9904 GBP | 31/12/2078 | Call |
Newsfile Corp
15:00
Elsevier Supports Pistoia Alliance in Accelerating Safe and Responsible AI Adoption in Drug Discover...
GlobeNewswire
12/08
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune...
GlobeNewswire
08/08
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets...
GlobeNewswire
06/08
FibroGen Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
26/06
As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire
18/06
Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire
18/06
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire
13/06
Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire
08/05
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
06/05
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
02/05
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
